These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 27339902)

  • 21. Inhibition of tumor-associated human carbonic anhydrase isozymes IX and XII by a new class of substituted-phenylacetamido aromatic sulfonamides.
    Akdemir A; Güzel-Akdemir O; Scozzafava A; Capasso C; Supuran CT
    Bioorg Med Chem; 2013 Sep; 21(17):5228-32. PubMed ID: 23842519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Carbonic anhydrase inhibitors. Synthesis of heterocyclic 4-substituted pyridine-3-sulfonamide derivatives and their inhibition of the human cytosolic isozymes I and II and transmembrane tumor-associated isozymes IX and XII.
    Sławiński J; Szafrański K; Vullo D; Supuran CT
    Eur J Med Chem; 2013 Nov; 69():701-10. PubMed ID: 24095761
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of 1,1'-Biphenyl-4-sulfonamides as a New Class of Potent and Selective Carbonic Anhydrase XIV Inhibitors.
    La Regina G; Coluccia A; Famiglini V; Pelliccia S; Monti L; Vullo D; Nuti E; Alterio V; De Simone G; Monti SM; Pan P; Parkkila S; Supuran CT; Rossello A; Silvestri R
    J Med Chem; 2015 Nov; 58(21):8564-72. PubMed ID: 26497049
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of 3,4-Dihydroisoquinoline-2(1H)-sulfonamides as potent carbonic anhydrase inhibitors: synthesis, biological evaluation, and enzyme--ligand X-ray studies.
    Gitto R; Agnello S; Ferro S; De Luca L; Vullo D; Brynda J; Mader P; Supuran CT; Chimirri A
    J Med Chem; 2010 Mar; 53(6):2401-8. PubMed ID: 20170095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 4-[N-(substituted 4-pyrimidinyl)amino]benzenesulfonamides as inhibitors of carbonic anhydrase isozymes I, II, VII, and XIII.
    Sūdžius J; Baranauskienė L; Golovenko D; Matulienė J; Michailovienė V; Torresan J; Jachno J; Sukackaitė R; Manakova E; Gražulis S; Tumkevičius S; Matulis D
    Bioorg Med Chem; 2010 Nov; 18(21):7413-21. PubMed ID: 20889345
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Quantum chemical QSAR models to distinguish between inhibitory activities of sulfonamides against human carbonic anhydrases I and II and bovine IV isozymes.
    Deeb O; Goodarzi M; Khadikar PV
    Chem Biol Drug Des; 2012 Apr; 79(4):514-22. PubMed ID: 22181786
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Benzenesulfonamide bearing 1,2,4-triazole scaffolds as potent inhibitors of tumor associated carbonic anhydrase isoforms hCA IX and hCA XII.
    SitaRam ; Celik G; Khloya P; Vullo D; Supuran CT; Sharma PK
    Bioorg Med Chem; 2014 Mar; 22(6):1873-82. PubMed ID: 24560737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissecting the inhibition mechanism of cytosolic versus transmembrane carbonic anhydrases by ESR.
    Ciani L; Cecchi A; Temperini C; Supuran CT; Ristori S
    J Phys Chem B; 2009 Oct; 113(42):13998-4005. PubMed ID: 19778001
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Carbonic anhydrase inhibitors. Regioselective synthesis of novel series 1-substituted 1,4-dihydro-4-oxo-3-pyridinesulfonamides and their inhibition of the human cytosolic isozymes I and II and transmembrane cancer-associated isozymes IX and XII.
    Brzozowski Z; Sławiński J; Vullo D; Supuran CT
    Eur J Med Chem; 2012 Oct; 56():282-91. PubMed ID: 22910138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides.
    Vullo D; Voipio J; Innocenti A; Rivera C; Ranki H; Scozzafava A; Kaila K; Supuran CT
    Bioorg Med Chem Lett; 2005 Feb; 15(4):971-6. PubMed ID: 15686895
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Substituted benzene sulfonamides incorporating 1,3,5-triazinyl moieties potently inhibit human carbonic anhydrases II, IX and XII.
    Saluja AK; Tiwari M; Vullo D; Supuran CT
    Bioorg Med Chem Lett; 2014 Mar; 24(5):1310-4. PubMed ID: 24507918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbonic anhydrase inhibitors: synthesis and inhibition studies against mammalian isoforms I-XV with a series of 2-(hydrazinocarbonyl)-3-substituted-phenyl-1H-indole-5-sulfonamides.
    Güzel O; Innocenti A; Scozzafava A; Salman A; Parkkila S; Hilvo M; Supuran CT
    Bioorg Med Chem; 2008 Oct; 16(20):9113-20. PubMed ID: 18819811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition pattern of sulfamide-related compounds in binding to carbonic anhydrase isoforms I, II, VII, XII and XIV.
    Gavernet L; Gonzalez Funes JL; Palestro PH; Bruno Blanch LE; Estiu GL; Maresca A; Barrios I; Supuran CT
    Bioorg Med Chem; 2013 Mar; 21(6):1410-8. PubMed ID: 23266178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro inhibition of α-carbonic anhydrase isozymes by some phenolic compounds.
    Oztürk Sarikaya SB; Topal F; Sentürk M; Gülçin I; Supuran CT
    Bioorg Med Chem Lett; 2011 Jul; 21(14):4259-62. PubMed ID: 21669522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis 4-[2-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-ethyl]-benzenesulfonamides with subnanomolar carbonic anhydrase II and XII inhibitory properties.
    Bozdag M; Alafeefy AM; Carta F; Ceruso M; Al-Tamimi AS; Al-Kahtani AA; Alasmary FAS; Supuran CT
    Bioorg Med Chem; 2016 Sep; 24(18):4100-4107. PubMed ID: 27396930
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Carbonic anhydrase inhibitors: inhibition of human cytosolic isozymes I and II and tumor-associated isozymes IX and XII with S-substituted 4-chloro-2-mercapto-5-methyl-benzenesulfonamides.
    Saczewski F; Innocenti A; Sławiński J; Kornicka A; Brzozowski Z; Pomarnacka E; Scozzafava A; Temperini C; Supuran CT
    Bioorg Med Chem; 2008 Apr; 16(7):3933-40. PubMed ID: 18242998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Conformational variability of different sulfonamide inhibitors with thienyl-acetamido moieties attributes to differential binding in the active site of cytosolic human carbonic anhydrase isoforms.
    Biswas S; Aggarwal M; Güzel Ö; Scozzafava A; McKenna R; Supuran CT
    Bioorg Med Chem; 2011 Jun; 19(12):3732-8. PubMed ID: 21620713
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Carbonic anhydrase inhibitors: inhibition of the human transmembrane isozyme XIV with a library of aromatic/heterocyclic sulfonamides.
    Ozensoy O; Nishimori I; Vullo D; Puccetti L; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2005 Nov; 13(22):6089-93. PubMed ID: 16006130
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and carbonic anhydrase inhibition of polycyclic imides incorporating N-benzenesulfonamide moieties.
    Angeli A; Abdel-Aziz AA; Nocentini A; El-Azab AS; Gratteri P; Supuran CT
    Bioorg Med Chem; 2017 Oct; 25(20):5373-5379. PubMed ID: 28789908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sulfonamide linked neoglycoconjugates--a new class of inhibitors for cancer-associated carbonic anhydrases.
    Lopez M; Bornaghi LF; Innocenti A; Vullo D; Charman SA; Supuran CT; Poulsen SA
    J Med Chem; 2010 Apr; 53(7):2913-26. PubMed ID: 20201556
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.